Literature DB >> 15385593

Cannabinoid agonist, CP 55,940, prevents capsaicin-induced sensitization of spinal cord dorsal horn neurons.

Lisa M Johanek1, Donald A Simone.   

Abstract

Low doses of cannabinoids applied intrathecally attenuate capsaicin-evoked heat and mechanical hyperalgesia via CB1 receptors. Although cannabinoids produce antinociception, in part, by attenuating responses of nociceptive neurons in the spinal cord, few studies have examined the effect of cannabinoids on sensitization of spinal neurons. We therefore investigated whether a cannabinoid receptor agonist, CP 55,940, attenuated excitation and sensitization of spinal nociceptive neurons produced by intraplantar injection of 0.1% capsaicin (10 microl). In rats, wide-dynamic-range (WDR) and high-threshold (HT) neurons were classified according to responses evoked by mechanical stimuli of varying intensity. CP 55,940 (10 microg in 50 microl) or vehicle was applied directly to the spinal cord and responses to mechanical (von Frey monofilament) and heat stimuli were recorded 10 min after drug treatment. CP 55,940 alone did not alter responses to mechanical stimuli; however the enhanced responses to mechanical stimuli after injection of capsaicin into the receptive field were dose dependently attenuated in both HT and WDR neurons. Vehicle-treated neurons increased their response to 300.6 +/- 52.1% of baseline after capsaicin, whereas CP 55,940-treated neurons responded at 153.0 +/- 27.1% of baseline. The effects of CP 55,940 on sensitization to heat were less pronounced; however, CP 55,940 attenuated the capsaicin-evoked decrease in heat threshold in HT neurons. The attenuation by CP 55,940 of sensitization to mechanical stimuli was blocked by pretreatment of the spinal cord with the CB1 receptor antagonist, SR141716A. These studies demonstrate that cannabinoid application to the spinal cord prevents central sensitization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385593     DOI: 10.1152/jn.00673.2004

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  6 in total

Review 1.  The endocannabinoid system and pain.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

2.  Hyperalgesia and sensitization of dorsal horn neurons following activation of NK-1 receptors in the rostral ventromedial medulla.

Authors:  Sergey G Khasabov; Patrick Malecha; Joseph Noack; Janneta Tabakov; Glenn J Giesler; Donald A Simone
Journal:  J Neurophysiol       Date:  2017-08-09       Impact factor: 2.714

3.  Attenuation of cannabinoid-induced inhibition of medullary dorsal horn neurons by a kappa-opioid receptor antagonist.

Authors:  Akiko Okada-Ogawa; Masayuki Kurose; Ian D Meng
Journal:  Brain Res       Date:  2010-08-31       Impact factor: 3.252

4.  Intrathecal administration of Resolvin D1 and E1 decreases hyperalgesia in mice with bone cancer pain: Involvement of endocannabinoid signaling.

Authors:  Iryna A Khasabova; Mikhail Y Golovko; Svetlana A Golovko; Donald A Simone; Sergey G Khasabov
Journal:  Prostaglandins Other Lipid Mediat       Date:  2020-07-31       Impact factor: 3.072

5.  Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative pain.

Authors:  C Z Zhu; J P Mikusa; Y Fan; P R Hollingsworth; M Pai; P Chandran; A V Daza; B B Yao; M J Dart; M D Meyer; M W Decker; G C Hsieh; P Honore
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

6.  Tumor-evoked hyperalgesia and sensitization of nociceptive dorsal horn neurons in a murine model of cancer pain.

Authors:  Sergey G Khasabov; Darryl T Hamamoto; Catherine Harding-Rose; Donald A Simone
Journal:  Brain Res       Date:  2007-09-14       Impact factor: 3.252

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.